Kolexia
Foucher Juliette Gastro-entérologie
Foucher Juliette
Gastro-entérologie
Hôpital Haut-lévêque
Pessac, France
102 Activités
100 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Cirrhose du foie Fibrose Hépatite Maladies du foie Stéatose hépatique non alcoolique Stéatose hépatique Hépatite C Hépatite chronique Hépatite C chronique

Collaborateurs

Voir plus
De Ledinghen Victor
De Ledinghen Victor
Hôpital Haut-lévêque, Pessac, France
Vergniol Julien
Vergniol Julien
Msp Bordeaux Bagatelle, Talence, France
Chermak Faiza
Chermak Faiza
Hôpital Haut-lévêque, Pessac, France
Hiriart Jean-Baptiste
Hiriart Jean-Baptiste
Hôpital Haut-lévêque, Pessac, France

Industries

Voir plus
Gilead
27 collaboration(s)
Dernière en 2023
Abbvie
12 collaboration(s)
Dernière en 2023
Edimark
4 collaboration(s)
Dernière en 2022
AEC PARTNERS SAS
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis.
European journal of neurology   21 août 2023
Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS).
Amyotrophic lateral sclerosis & frontotemporal degeneration   31 juillet 2023
PVNIM: Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease. a Retrospective and Prospective 20-year Follow-up.
Essai Clinique (CHU Bordeaux)   19 juillet 2023
PVTE: Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease. A Prospective Follow-up of 4,935 Person-years
Essai Clinique (CHU Bordeaux)   19 juillet 2023
Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods.
Alimentary pharmacology & therapeutics   03 janvier 2022
Global real-world evidence of sofosbuvir/velpatasvir (SOF/VEL) as a highly effective treatment in underserved patient populations because of mental health disorders, incarceration or homelessness
Oral presentations at the XVI National Congress of the Mexican Association of Hepatology 2022   01 janvier 2022
Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use.
Liver international : official journal of the International Association for the Study of the Liver   12 novembre 2021
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus.
World journal of hepatology   16 février 2021
Diagnostic non invasif de cirrhose dans la « non-alcoholic fatty liver disease » (NAFLD)
15-16 septembre   01 septembre 2020
Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
Clinical and translational gastroenterology   03 août 2020